tradingkey.logo

Prestige Consumer Healthcare Inc

PBH
View Detailed Chart
66.330USD
+0.780+1.19%
Close 02/06, 16:00ETQuotes delayed by 15 min
3.19BMarket Cap
17.43P/E TTM

Prestige Consumer Healthcare Inc

66.330
+0.780+1.19%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.19%

5 Days

+2.89%

1 Month

+5.69%

6 Months

-11.75%

Year to Date

+7.52%

1 Year

-24.06%

View Detailed Chart

Key Insights

Prestige Consumer Healthcare Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 8 out of 159 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 77.25.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Prestige Consumer Healthcare Inc's Score

Industry at a Glance

Industry Ranking
8 / 159
Overall Ranking
30 / 4521
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Prestige Consumer Healthcare Inc Highlights

StrengthsRisks
Prestige Consumer Healthcare Inc. is a consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Overvalued
The company’s latest PE is 17.43, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 53.07M shares, decreasing 0.79% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 58.06K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.12.

Analyst Rating

Based on 6 analysts
Buy
Current Rating
77.250
Target Price
+17.85%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Prestige Consumer Healthcare Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Prestige Consumer Healthcare Inc Info

Prestige Consumer Healthcare Inc. is a consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Ticker SymbolPBH
CompanyPrestige Consumer Healthcare Inc
CEOLombardi (Ronald M)
Websitehttps://www.prestigebrands.com/
KeyAI